Oral Bifidobacterium longum expressing alpha-melanocyte-stimulating hormone to fight experimental colitis

Drug Delivery

Volumn 23, Issue 6, 2016, Pages 2058-2064

  Wei, Pijin ^a   Yang, Yan ^a   Liu, Zhaobing ^a   Huang, Junli ^a   Gong, Yahui ^a   Sun, Hanxiao ^a  

^a JINAN UNIVERSITY   (China)

Author keywords

Bifidobacterium; colitis; peptide delivery; MSH

Indexed keywords

ALPHA INTERMEDIN; ANTIINFLAMMATORY AGENT; DEXTRAN SULFATE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MYELOPEROXIDASE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BIFIDOBACTERIUM LONGUM; COLON INJURY; CONTROLLED STUDY; DRUG EFFICACY; ENZYME ACTIVITY; EXPERIMENTAL ULCERATIVE COLITIS; HISTOPATHOLOGY; HT 29 CELL LINE; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; RECOMBINANT DNA TECHNOLOGY; TREATMENT OUTCOME; ANIMAL; CHEMISTRY; COLON; DRUG EFFECTS; HT-29 CELL LINE; METABOLISM;

ALPHA-MSH; ANIMALS; ANTI-INFLAMMATORY AGENTS; BIFIDOBACTERIUM LONGUM; COLON; DEXTRAN SULFATE; HT29 CELLS; HUMANS; INTERLEUKIN-10; MICE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84949816734     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.3109/10717544.2015.1122672     Document Type: Article

References (30)

1. T.A.Ayoubi, J.W.Creemers, A.J.Roebroek,. (1994). Expression of the dibasic proprotein processing enzyme furin is directed by multiple promoters. J Biol Chem 269:9298–303.
2. T.Brzoska, M.Böhm, A.Lügering,. (2010). Terminal signal: anti-inflammatory effects of α-melanocyte stimulating hormone related peptides beyond the pharmacophore. Adv Exp Med Biol 681:107–16.
3. T.Brzoska, T.A.Luger, C.Maaser,. (2008). αMelanocyte stimulating hormone and related tripeptides: biochemistry, antiinflammatory and protective effects in vitro and in vivo, and future perspectives for the treatment of immune-mediated inflammatory diseases. Endocrine Rev 29:581–602.
4. J.Chin, K.A.F.Mahmud, S.Kim,. (2012). Insight of current technologies for oral delivery of proteins and peptides. Drug Discov Today Technol 9:e171–4.
5. B.F.Choonara, Y.E.Choonara, P.Kumar,. (2014). A review of advanced oral drug delivery technologies facilitating the protection and absorption of protein and peptide molecules. Biotechnol Adv 32:1269–82.
6. J.Fichna, M.Dicay, K.Lewellyn,. (2012). Salvinorin A has antiinflammatory and antinociceptive effects in experimental models of colitis in mice mediated by KOR and CB1 receptors. Inflamm Bowel Dis 18:1137–45.
7. G.F.Fu, X.Li, Y.Y.Hou,. (2005). Bifidobacterium longum as an oral delivery system of endostatin for gene therapy on solid liver cancer. Cancer Gene Ther 12:133–40.
8. A.Gambero, M.Maróstica, M.J.Abdalla Saad, J.Pedrazzoli, Jr. (2007). Mesenteric adipose tissue alterations resulting from experimental reactivated colitis. Inflamm Bowel Dis 13:1357–64.
9. F.P.Gendron, S.Mongrain, P.Laprise,. (2006). The CDX2 transcription factor regulates furin expression during intestinal epithelial cell differentiation. Am J Physiol Gastrointest Liver Physiol 290:G310–8.
10. S.Henrich, A.Cameron, G.P.Bourenkov,. (2003). The crystal structure of the proprotein processing proteinase furin explains its stringent specificity. Nat Struct Mol Biol 10:520–6.
11. J.M.Lipton (1990). Modulation of host defense by the neuropeptide alpha-MSH. Yale J Biol Med 63:173–82
12. T.A.Luger, T.Brzoska (2007). αMSH related peptides: a new class of anti-inflammatory and immunomodulating drugs. Ann Rheum Dis 66:52–5.
13. D.Matteuzzi, P.Brigidi, M.Rossi, D.Di (1990). Characterization and molecular cloning of Bifidobacterium longum cryptic plasmid pMB1. Lett Appl Microbiol 11:220–3.
14. A.Muheem, F.Shakeel, M.A.Jahangir,. (2014). A review on the strategies for oral delivery of proteins and peptides and their clinical perspectives. Saudi Pharm J. [Epub ahead of print]. doi:10.1016/j.jsps.2014.06.004.
15. M.G.Neuman (2007). Immune dysfunction in inflammatory bowel disease. Transl Res 149:173–86.
16. J.T.Oatley, M.D.Rarick, G.E.Ji, J.E.Linz (2000). Binding of aflatoxin B1 to bifidobacteria in vitro. J Food Prot 63:1133–6.
17. K.Park, I.C.Kwon, K.Park (2011). Oral protein delivery: current status and future prospect. React Funct Polym 71:280–7.
18. M.S.Park, B.Kwon, J.J.Shim,. (2008). Heterologous expression of cholesterol oxidase in Bifidobacterium longum under the control of 16S rRNA gene promoter of bifidobacteria. Biotechnol Lett 30:165–72.
19. M.S.Park, J.M.Seo, J.Y.Kim, G.E.Ji (2005). Heterologous gene expression and secretion in Bifidobacterium longum. Lait 85:1–8.
20. N.Rajora, G.Boccoli, A.Catania, J.M.Lipton (1997). alpha-MSH modulates experimental inflammatory bowel disease. Peptides 18:381–5.
21. M.L.Reyes Escogido, A.De León Rodríguez, A.P.Barba de la Rosa (2007). A novel binary expression vector for production of human IL-10 in Escherichia coli and Bifidobacterium longum. Biotechnol Lett 29:1249–53.
22. M.Rossi, P.Brigidi, D.Matteuzzi (1997). An efficient transformation system for Bifidobacterium spp. Lett Appl Microbiol 24:33–6.
23. A.Rubinstein (2005). Colonic drug delivery. Drug Discov Today Technol 2:33–7.
24. J.Sambrook, D.W.Russell (2001). Molecular cloning: a laboratory manual. New York: Cold Spring Harbor Laboratory Press.
25. F.Sanchez-Munoz, A.Dominguez-Lopez, J.K.Yamamoto-Furusho (2008). Role of cytokines in inflammatory bowel disease. World J Gastroenterol 14:4280–8.
26. M.Singh, K.Mukhopadhyay (2014). Alpha-melanocyte stimulating hormone: an emerging anti-inflammatory antimicrobial peptide. Biomed Res Int 2014:874610
27. P.Tian, B.Xu, G.An,. (2014). A new therapies for intestinal flora imbalance used ampicillin resistant probiotics. J Microbiol Biotechnol 24:1300–12.
28. J.Trifunović, L.Miller, Ž.Debeljak, V.Horvat (2015). Pathologic patterns of interleukin 10 expression-a review. Biochem Med 25:36–48.
29. C.Van Kemseke, J.Belaiche, E.Louis (2000). Frequently relapsing Crohn’s disease is characterized by persistent elevation in interleukin-6 and soluble interleukin-2 receptor serum levels during remission. Int J Colorectal Dis 15:206–10.
30. G.Xu, S.L.Bell, D.McCool,. (2000). The cationic C-terminus of rat Muc2 facilitates dimer formation post translationally and is subsequently removed by furin. Eur J Biochem 267:2998–3004.